Growth hormone (GH) excess is associated with secondary hyperinsulinemia, but the molecular mechanism and consequences of this alteration are poorly understood. To address this problem we have examined the levels and phosphorylation state of the insulin receptor (IR) and the insulin receptor substrate-1 (IRS-1), the association between IRS-1 and the p85 subunit of phosphatidylinositol 3-kinase (PI 3-kinase) as well as the PI 3-kinase activity in the livers of GH-transgenic mice. As expected, IR levels were reduced in the liver of GH-transgenic mice (55% of normal values) as determined by immunoblotting with an anti-IR -subunit antibody. IR and IRS-1 phosphorylation as determined by immunoblotting with antiphosphotyrosine antibody were increased in basal conditions by 315% and 560% respectively. After a bolus administration of insulin in vivo, IR phosphorylation increased by 40% while IRS-1 phosphorylation did not change. Insulin administration to control (normal) mice produced 670% and 300% increases in the IR and IRS-1 phosphorylation respectively. In the GH-transgenic animals, basal association of PI 3-kinase with IRS-1 as well as PI 3-kinase activity in liver was increased by 200% and 280% respectively, and did not increase further after administration of insulin in vivo, indicating a complete insensitivity to insulin at these levels. In conclusion, GH excess and the resulting secondary hyperinsulinemia were associated with alterations at the early steps of insulin action in liver. IR concentration was reduced, while IR and IRS-1 phosphorylation, IRS-1/PI 3-kinase association, and PI 3-kinase activity appeared to be maximally activated under basal conditions, thus making this tissue insensitive to further stimulation by exogenous insulin in vivo.
Introduction
Chronic elevation of growth hormone (GH) induces resistance to insulin and hyperinsulinemia in both humans and animals (Davidson 1987) . This is observed in acromegalic patients (Beck et al. 1965 , Trimble et al. 1980 , Hansen et al. 1986 ) and in rats with GH secreting tumors (Davidson & Melmed 1983 , Venkatesan & Davidson 1995 . Exogenous administration of GH also leads to insulin resistance in man (Rizza et al. 1982 , Moller et al. 1993 and animals (Ader et al. 1987 , Ng et al. 1990 ). However, little is known about the molecular mechanism involved in this alteration.
Insulin initiates its diverse biological actions by binding to a membrane-bound glycoprotein receptor, which triggers a cascade of intracellular phosphorylation events (White & Kahn 1994) . Insulin binding to the insulin receptor (IR) -subunit activates the tyrosine kinase activity intrinsic to the -subunit (Kasuga et al. 1982) . The preponderance of current data suggest that most of the biological effects of insulin are mediated by the insulin receptor tyrosine kinase (Morgan et al. 1986 , Chou et al. 1987 . Insulin receptor substrate 1 (IRS-1) is the major substrate of the IR kinase and has many tyrosine phosphorylation sites which provide several binding sites for specific proteins containing Src homology 2 (SH2) domains (Sun et al. 1991 , Myers & White 1995 . Therefore, IRS-1 appears to act as a docking molecule coupling the IR to downstream molecules involved in the insulin signaling pathway.
The lipid metabolizing enzyme, phosphatidylinositol 3-kinase (PI 3-kinase), is one of the SH2 domaincontaining proteins. When it is tyrosine phosphorylated, IRS-1 binds the p85 subunit of PI 3-kinase, thereby activating this enzyme leading to the stimulation of glucose transport into cells (Cheatham et al. 1994 , Le Marchand-Brustel et al. 1995 , stimulation of glycogen synthesis (Shepherd et al. 1996) and activation of the p70 S6 kinase (Cheatham et al. 1994 , Chung et al. 1994 . Thus, activation of PI 3-kinase by insulin seems to be essential for insulin's regulation of metabolism (Shepherd et al. 1996) .
In cultured cells (Souza et al. 1994 , Ridderstrale et al. 1995 and in livers of intact mice (Yamauchi et al. 1998) , GH has been shown to stimulate tyrosine phosphorylation of IRS-1 and its association with PI 3-kinase. Therefore, interaction of the insulin and GH signaling pathways at these levels may be of physiological relevance. To study the connection between GH and insulin, we have used transgenic mice overexpressing bovine (b) GH. Exposure since birth to high levels of circulating GH in these animals leads to a state of insulin resistance (Valera et al. 1993 , Balbis et al. 1996 . In previous studies, we observed a decrease in the IR concentration in livers from these animals, together with increased receptor tyrosine kinase and autophosphorylation activity, which led us to conclude that the insulin resistance observed in these mice may be a consequence of a post-receptor defect in the insulin signaling pathway (Balbis et al. 1996 , Dominici et al. 1998 . In the present study, we continued our study of this model by evaluating the in vivo tyrosine phosphorylation of the IR and the IRS-1, the association between PI 3-kinase and IRS-1, as well as the phosphotyrosineassociated PI 3-kinase activity after insulin administration in the liver of normal and bGH-transgenic mice. In addition, the abundance of these three proteins (IR, IRS-1 and PI 3-kinase) in the liver was determined.
Materials and Methods

Materials
HEPES, Tris, phenylmethylsulfonyl fluoride (PMSF), aprotinin, ATP, phosphatidylinositol, phosphatidylinositol 4-monophosphate, Triton X-100, Tween 20, porcine insulin, and bovine serum albumin (fraction V) (BSA) were from Sigma Chemical Co. (St Louis, MO, USA). Silica gel thin-layer chromatography (TLC) plates were from Merck (Darmstadt, Germany), protein A-Sepharose 6MB was from Pharmacia (Uppsala, Sweden). [
125 I]Protein A was purchased from ICN Biomedicals (Costa Mesa, CA, USA), [ -32 P]ATP was from Dupont-NEN (Boston, MA, USA), and Immobilon P membranes were from Millipore (Bedford, MA, USA). The reagents and apparatus for SDS-PAGE and immunoblotting were from Bio-Rad Laboratories (Richmond, CA, USA). A monoclonal anti-phosphotyrosine antibody (PY20) was obtained from Transduction Laboratories (Lexington, KY, USA). Polyclonal anti-insulin receptor -subunit antibody was from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti-IRS-1 antibody and anti-p85 subunit of PI-3-kinase antibodies were from Upstate Biotechnology (Lake Placid, NY, USA).
Animals
Female transgenic mice and their normal female siblings used in this work were derived from animals kindly provided by Dr Thomas E Wagner and Jeung S Yun (Ohio University, Athens, OH, USA). These animals were originally produced by microinjection of the bGH gene fused to the control sequences of the rat phosphoenolpyruvate carboxykinase gene (PEPCK-bGH) into the pronuclei of fertilized mouse eggs (McGrane et al. 1988) . The hemizygous transgenic mice used in the present study were derived from a founder male with approximately 25 copies of the hybrid gene, and were produced by mating transgenic males with normal C57BL/6 C3H F 1 hybrid females purchased from the Jackson Laboratory (Bar Harbor, ME, USA). These matings produced approximately equal numbers of transgenic and normal progeny. Normal siblings of transgenic mice were used as controls. Transgenic animals had markedly accelerated postweaning growth, leading to a significant increase in body weight at the age of 3-5 months when the mice were used. Animals were housed 3-5 per cage in a room with controlled light (12 h light/day) and temperature (22 2 C) with free access to food (Lab Diet, Formulab 5008 containing a minimum of 23% protein, 6·5% fat, and a maximum of 4% fiber; PMI Feeds Inc., St Louis, MO, USA) and tap water.
Measurement of plasma insulin and GH concentrations
The fasting plasma insulin concentration was determined using a solid phase radioimmunoassay kit from DPC (Diagnostic Products Inc., Los Angeles, CA, USA).
Bovine GH levels were determined as previously described (Balbis et al. 1996) .
Preparation of liver extracts
The mice were fasted for 12 h, and 15 min before the experiment they were anesthetized by intraperitoneal administration of 100 mg sodium pentobarbital per kg body weight. The portal vein was exposed and 10 IU insulin per kg body weight in normal saline (0·9% NaCl) in a final volume of 0·1 ml were injected via this vein. Control and transgenic mice which had been injected only with diluent were used to evaluate changes under basal conditions. Approximately 40 seconds after injection, blood samples were taken under anesthesia from the heart and the livers were removed, homogenized in 10 volumes of solubilization buffer A (1% Triton, 100 mM Tris (pH 7·4), 100 mM sodium pyrophosphate, 100 mM sodium fluoride, 10 mM EDTA, 10 mM sodium vanadate, 2 mM PMSF, and 0·1 mg/ml aprotinin) at 4 C. Liver extracts were centrifuged at 40 000 r.p.m. at 4 C in a Beckman 90 Ti rotor (Palo Alto, CA, USA) for 40 min to eliminate insoluble material. Protein concentration was determined by the method described by Bradford (1976) , and the supernatants were used for immunoprecipitation with anti-IRS-1 or anti-IR antibodies.
Immunoprecipitation
Liver homogenates containing 7·5 mg total protein prepared as described above were incubated at 4 C overnight with anti-IR antibody or with anti-IRS-1 antibody. After incubation, 50 µl protein A-Sepharose (50%, v/v) were added to the mixture. The preparation was further incubated with constant rocking for 2 h at 4 C and centrifuged at 3000 g for 1 min at 4 C. The supernatant was discarded and the precipitate was washed three times with homogenizing buffer A. The final pellet was resuspended in 40 µl reducing sample buffer, boiled for 5 min, and stored at 80 C until electrophoresis.
Immunoblotting
Samples were subjected to electrophoresis on a 7% polyacrylamide gel using a Bio-Rad Mini Protean apparatus (Bio-Rad Laboratories). Electrotransfer of proteins from the gel to Immobilon P membranes was performed for 2 h at 100 V (constant) using the Bio-Rad miniature transfer apparatus in 25 mM Tris, 192 mM glycine, 20% (v/v) methanol, and 0·02% SDS. To reduce non-specific antibody binding, the polyvinylidene difluoride membranes were incubated at 4 C overnight in blocking buffer composed of TBS-T buffer (10 mM Tris-HCl, pH 7·6, 150 mM NaCl, and 0·02% Tween 20) containing either 3% BSA for phosphotyrosine detection or 5% BSA for protein detection. The membranes were then incubated for 4 h at room temperature with anti-phosphotyrosine ( PY) (1 µg/ml), anti-insulin receptor (1:250), or anti-IRS-1 (1 µg/ml) antibodies diluted in the corresponding blocking buffer. The membranes were subjected to four 5-min washes in TBS-T buffer and were then incubated with 3 µCi [ 125 I]protein A (30 µCi/µg) in 15 ml blocking buffer for 1 h at room temperature and then washed again for 60 min as described above. [
125 I]Protein A bound to antibodies was detected by autoradiography using preflashed Kodak XAR film (Eastman Kodak, Rochester, NY, USA) at 70 C for 6-72 h. Band intensities were quantitated by optical densitometry (Densitometer model CS-930, Shimadzu, Japan) of the developed autoradiographs.
The amount of the p85 subunit of the PI 3-kinase in IRS-1 immunoprecipitates was evaluated by stripping the membranes and reblotting as follows: the blots which had been blotted with PY were rinsed, incubated in 2% SDS, 60 mM Tris, pH 6·7, 100 mM -mercaptoethanol at 50 C for 30 min, and reprobed again without adding additional primary antibody to check that all antibody had been removed. The membranes were then blocked for 2 h at room temperature with 5% non-fat dry milk in TBS-T buffer and incubated with anti-PI 3-kinase antibody ( p85) (1:2000) in TBS-T plus 1% non-fat dry milk. Bound antibodies were detected by incubation with [ 125 I]protein A as described above.
To determine the abundance of p85 in liver, aliquots containing equal amounts of solubilized proteins (200 µg) were separated by SDS-PAGE, and subjected to immunoblotting with p85. Bound antibodies were detected by incubation with [
125 I]protein A as described above. Quantitation of specific protein bands was performed by densitometry.
Measurement of PI 3-kinase activity in anti-phosphotyrosine immunoprecipitates
This determination was performed essentially as described by Carvalho et al. (1996) . Livers of control and transgenic mice which had been injected with or without insulin as described above were extracted and homogenized in buffer B (50 mM HEPES (pH 7·4), 137 mM NaCl, 1 mM MgCl 2 , 1 mM CaCl 2 , 2 mM Na 3 VO 4 , 10 mM Na 4 P 2 O 7 , 100 mM NaF, 2 mM EDTA, 2 mM PMSF, 2 mM aprotinin, 2 mM leupeptin, 10% (v/v) glycerol, and 1% Triton X-100) at 4 C. The homogenate was centrifuged at 100 000 g for 1 h at 4 C. Liver homogenates containing 7·5 mg total protein or muscle homogenates containing 5 mg total protein were incubated overnight at 4 C with an anti-phosphotyrosine antibody (5 µg). Immunocomplexes were collected by addition of 100 µl of a 50% (v/v) slurry of protein A-Sepharose in solubilization buffer and further incubation for 2 h at 4 C. After incubation, the immunoprecipitates were washed three times with icecold PBS (pH 7·4), containing 1% Triton X-100 and 100 µM Na 3 VO 4 , three times in ice-cold 100 mM Tris (pH 7·5) containing 100 mM LiCl 2 and 100 µM Na 3 VO 4 , and twice with ice-cold Tris 10 mM (pH 7·5) containing 100 mM NaCl, 1 mM EDTA, and 100 µM Na 3 VO 4 . The precipitates were then resuspended in 50 µl ice-cold 10 mM Tris, pH 7·5, containing 100 mM NaCl, 1 mM EDTA, 10 µl 100 mM MgCl 2 , and 20 µg phosphatidylinositol sonicated in 10 mM Tris (pH 7·5), 1 mM EDTA. The reaction was started by the addition of 10 µl 440 µM ATP containing 10 µCi [ -32 P]ATP. After 10 min at room temperature with constant shaking, the reaction was terminated by the addition of 20 µl 8 M HCl and 160 µl methanol-chloroform (1:1). Mixtures were centrifuged and the lower organic phase applied to silica TLC plates (Merck) coated with 1% (w/v) potassium oxalate. TLC plates were developed in CHCl 3 :CH 3 OH:H 2 O:NH 4 OH (60:47:11·3:2) and visualized by autoradiography. Phosphatidylinositol 4-phosphate, which co-migrates with 3-phosphorylated phosphatidylinositol, was used as standard.
32 P incorporated into phosphatidylinositol was quantitated by optical densitometry as described above.
Statistical analysis
Results are expressed as means ..., and were obtained studying all groups of animals in parallel. For
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Results
Data concerning body weight, plasma glucose, insulin, and GH concentrations of the studied animals (n=12 per group) are summarized in Table 1 . Overexpression of GH in transgenic mice led to a significant (P<0·01) twofold increase in body weight and induced an insulin resistant state evidenced by the concomitant presence of normal fasting glucose levels and grossly elevated basal plasma insulin concentrations (4-to 8-fold above normal levels; P<0·01).
Insulin receptor and IRS-1 tyrosine phosphorylation and abundance in the liver
Liver extracts were immunoprecipitated with an antiinsulin receptor -subunit antibody ( IR). The resulting immunoprecipitates were subjected to immunoblot analysis using an anti-phosphotyrosine antibody ( PY). Receptor autophosphorylation was quantified by scanning densitometry and data were expressed as a percentage of controls using the mean value of insulin-stimulated controls as 100%. Basal autophosphorylation (after saline injection) was increased by 315% in livers from transgenic mice (54 13 vs 13 6%; P<0·05; n=6 per group) when compared with controls ( Fig. 1A and B) . Exogenous administration of insulin (10 IU/kg body weight) produced a 670% increase in the level of autophosphorylation of the insulin receptor in control mice (P<0·001). Although a 40% increase in the IR phosphorylation level was observed in transgenic mice after insulin administration, this apparent change did not reach statistical significance (Fig. 1A,B) , suggesting decreased sensitivity of the IR to insulin in this tissue. As shown in Fig. 1C and D, the protein content of the IR was found to be decreased in livers of transgenic mice (55 9% of normal values; P<0·001; n=12 per group). Hepatic IR phosphorylation in vivo, corrected by the IR concentration (phosphate/protein ratio), was increased in transgenic animals by approximately 500% and 40% in basal conditions and after insulin stimulation respectively. IRS-1 was immunoprecipitated from liver homogenates of control and transgenic mice using a specific anti-IRS-1 antibody ( IRS-1). Tyrosine phosphorylation was detected by immunoblotting using PY. Basal tyrosine phosphorylation of IRS-1 was increased by approximately 560% in transgenic vs normal mice (165 38 vs 25 10%; P<0·05; n=6 per group) ( Fig. 2A and B) . After insulin administration, the tyrosine phosphorylation of IRS-1 increased 4-fold in control animals (P<0·01; n=6). In contrast, in livers from transgenic mice no significant changes in IRS-1 tyrosine phosphorylation were detected after insulin administration ( Fig. 2A,B) . This would suggest that hepatic IRS-1 in transgenic animals is close to being fully phosphorylated in basal conditions and thus unable to be stimulated further by insulin.
There was considerable variability in IRS-1 protein levels among transgenic mice. When the results were evaluated by densitometry, the mean value of IRS-1 abundance in liver was numerically higher in the GHtransgenic than in normal mice, but this apparent difference did not reach statistical significance (154 28% of control; P<0·07; n=12 per group) (Fig. 2C,D) .
PI 3-kinase association with IRS-1 and phosphotyrosine immunoprecipitable activity in liver
We have evaluated the influence of GH overexpression on both the association of the p85 subunit of PI 3-kinase with IRS-1 and the PI 3-kinase activity derived from PY immunoprecipitates. Following phosphotyrosine detection, the blots of liver samples which had previously been immunoprecipitated with -IRS-1 were stripped and reblotted with p85. In the basal state, the content of p85 in the anti-IRS-1 immunoprecipitates was increased by approximately 200% in transgenic mice when compared with controls (127 22 vs 43 3%; P<0·05; n=6 per group; Fig. 3A and B) . In control animals, the intensity of this band after insulin administration increased by approximately twofold (P<0·001; n=6; Fig. 3A,B) . In the GHtransgenic mice, the amount of p85 associated with IRS-1 did not change significantly after insulin administration (Fig. 3A,B) , consistent with the results concerning IRS-1 phosphorylation.
Hepatic PI 3-kinase activity was measured in immunocomplexes derived from phosphotyrosine antibody. As shown in Fig. 4A and B, basal PI 3-kinase activity in control animals was low and increased 3-to 5-fold after insulin administration. In GH-transgenic mice, basal PI 3-kinase activity was nearly four times greater than in the controls (80 18 vs 21 8%; n=6 per group; P<0·05). Moreover, in contrast to the findings in normal animals, it was only slightly (not significantly) increased after insulin administration (Fig. 4A,B) . Thus, results concerning the hepatic PI 3-kinase activity are concordant with those concerning the IR and IRS-1 phosphorylation.
To determine whether the alterations in the amount of IRS-1/PI 3-kinase complexes and the activity of PI 3-kinase were associated with changes in the total content of PI 3-kinase, liver extracts were immunoblotted with p85. We found no significant alterations in the hepatic levels of this protein in transgenic as compared with normal mice (n=6 per group; Fig. 4C,D) .
Discussion
The fact that an increase in plasma GH concentrations induces resistance to the action of insulin is well documented (Davidson 1987) . Excessive endogenous GH production in acromegaly (Beck et al. 1965 , Trimble et al. 1980 , Hansen et al. 1986 or exogenous GH administration (Rizza et al. 1982 , Ader et al. 1987 , Ng et al. 1990 ) causes insulin resistance and/or insulin insensitivity in different target tissues. The present study was undertaken to investigate the mechanisms by which GH induces insulin insensitivity. We have investigated the effects of chronic exposure to high GH levels on early steps of the insulin signaling system using a transgenic model of mice expressing high levels of heterologous GH (Balbis et al. 1996 , Dominici et al. 1998 . The general characteristics of these animals include increased body weight and severe hyperinsulinemia concomitant with normoglycemia (Valera et al. 1993 , Balbis et al. 1996 , Table 1), thus resembling the features of acromegalic patients (Trimble et al. 1980 , Hansen et al. 1986 . Moreover, the expression and activity of most of the key enzymes involved in carbohydrate metabolism is reduced in the liver and muscle from these mice (Valera et al. 1993) . Thus, the GH-transgenic mice appear to be well suited for studying long-term effects of GH in an intact animal.
After insulin binds to its receptor, the autophosphorylation of the IR following tyrosine phosphorylation of the IRS-1 and activation of PI 3-kinase represent the first steps in insulin action (White & Kahn 1994 , Myers & White 1995 . By making use of anti-peptide and antiphosphotyrosine antibodies, it is possible to assess these elements of the insulin signaling system in intact animals (Tobe et al. 1990 , Folli et al. 1992 . Thus, in the present study we have measured the phosphorylation state of the IR and IRS-1, association of this substrate with PI 3-kinase, and phosphotyrosine-derived PI 3-kinase activity after insulin stimulation in vivo in the liver of GH-transgenic mice.
The levels of IR protein were decreased in liver of GH-transgenic mice (Fig. 1A,B) as expected from the results of previous studies of insulin binding and immunoblotting assays in our laboratory (Balbis et al. 1996 , Dominici et al. 1998 . We have demonstrated that this reduction reflects down-regulation due to hyperinsulinemia rather than a direct effect of GH on the receptor in this tissue (Dominici et al. 1998) . Moreover, we have previously determined that GH overexpression in bGHtransgenic mice is associated with an increase in both the hepatic IR tyrosine kinase activity (Balbis et al. 1996) and autophosphorylation (Dominici et al. 1998) . In the present study, we found an increase in both basal and insulinstimulated tyrosine phosphorylation levels of the IR Figure 2 Hepatic IRS-1 phosphorylation and abundance in normal control and GH-transgenic mice. Animals were anesthetized, and normal saline (-) or insulin (10 IU/kg) (+) was injected into the portal vein. After 40 s the liver was excised and extracts were prepared as described in Materials and Methods. (A) Equal amounts of solubilized liver protein were immunoprecipitated (IP) with IRS-1, separated by SDS-PAGE and subjected to immunoblot analysis using PY. Two animals per group were studied in each experiment. in vivo. After insulin administration, the hepatic IR phosphorylation in transgenic mice appeared to increase, but this change did not reach statistical significance. These findings suggest that there is an important insensitivity to insulin in this organ. Our results agree with the increased hepatic IR autophosphorylation and tyrosine kinase activity in another model of GH excess, namely rats harboring GH-secreting tumors (Venkatesan & Davidson 1995) .
In a recent study, no changes were found in the concentration of the IR in the livers of rats made insulin resistant by exogenous administration of GH (Thirone et al. 1997) . Circulating insulin levels in GH-transgenic mice (Table 1 ) are approximately sevenfold above normal values, while only a twofold increase was detected in GH-treated rats (Thirone et al. 1997) . Therefore, the difference in insulin levels between these two models as well as differences in the levels and dynamics of GH (continuous endogenous production versus exogenous administration by injection) may account for this discrepancy.
The in vivo level of IRS-1 tyrosine phosphorylation in liver from GH-transgenic mice was greatly increased in basal conditions. However, IRS-1 phosphorylation did not increase further after stimulation with insulin in vivo, suggesting that IRS-1 in liver from GH-transgenic mice is close to being maximally phosphorylated under basal conditions. This may be secondary to the increase in the basal IR phosphorylation detected in these animals. Elevation of plasma GH levels may also be involved, since GH can stimulate tyrosine phosphorylation of IRS-1 both in vitro (Souza et al. 1994 , Ridderstrale et al. 1995 , and in vivo (Yamauchi et al. 1998) . The recent report by Yamauchi et al. (1998) has suggested that, in the liver, a major target tissue for GH (Kelly et al. 1991) , IRS-1 phosphorylation via activation of the Janus kinase 2 ( JAK2) may play an important role in GH signal transduction. The observed alterations in IRS-1 phosphorylation in liver from GH-transgenic mice may result at least partially from the interaction of GH and insulin at that level.
One of the earliest events that can be detected after the binding of insulin to its receptor and the receptor autophosphorylation is the activation of PI 3-kinase (Ruderman et al. 1990 ). Activation of PI 3-kinase activity by insulin is mediated by the interaction between the p85 subunit of this enzyme and IRS-1 , Folli et al. 1992 . The available information suggests that insulin stimulation of PI 3-kinase is essential for insulin's regulation of metabolism (Cheatham et al. 1994 , Chung et al. 1994 , Shepherd et al. 1996 . Therefore, we were interested in measuring the association of PI 3-kinase with IRS-1 and the corresponding activity of this enzyme in livers of GH-transgenic mice in order to extend the characterization of the effects of GH excess on the insulin signaling cascade. In addition, the information obtained would verify the observations made at the level of IRS-1 phosphorylation.
Our results show that both the association of PI 3-kinase with IRS-1 and the PI 3-kinase activity are dramatically increased in livers from GH-transgenic mice in the basal state. These alterations correlate well with the changes observed at the level of IRS-1 tyrosine phosphorylation. As no significant changes were found after administration of a dose of insulin sufficient to result in a large activation of these steps of the insulin signaling cascade in the control group, we can conclude that both the association of IRS-1 with PI 3-kinase and the activity of this enzyme are maximally stimulated in the liver of GH-transgenic mice in basal conditions. Elevated GH levels could be responsible for these changes. In cultured cells, GH has been shown to stimulate PI 3-kinase activity (Ridderstrale et al. 1995 , Kilgour et al. 1996 . Similar results were observed in mouse liver in vivo (Yamauchi et al. 1998) . In that work it Figure 3 Association of PI 3-kinase with IRS-1 in livers from normal control and GH-transgenic mice. Animals were anesthetized, and normal saline (-) or insulin (10 IU/kg) (+) was injected into the portal vein. Liver proteins were isolated as described in Materials and Methods. After centrifugation, aliquots from the supernatants containing equal amounts of protein (7·5 mg) were immunoprecipitated (IP) with IRS-1 and immunoblotted with p85. Two animals per group were studied in each experiment (A). In (B) data (means S.E.M.) of scanning densitometry performed on autoradiograms from three separate experiments (n=6 per group) are shown. *P<0·05 versus saline-treated control mice.
was demonstrated that the activation of PI 3-kinase by GH is mediated mainly by IRS-1 tyrosine phosphorylation. However, the extent of PI 3-kinase stimulation by GH was only a fraction of that observed after insulin infusion under the same conditions (Yamauchi et al. 1998) . Our results support the findings of Yamauchi et al. (1998) , since the exclusive step in the insulin signaling pathway (activation of IR by phosphorylation) was not maximal under basal conditions, as occurred with the subsequent signaling steps analyzed, which could be shared by insulin and GH (Yamauchi et al. 1998) .
We used acute administration of insulin (40 seconds) as a tool in order to measure the maximal phosphorylation of the pre-existing quantities of the IR, IRS-1, as well as p85 association with IRS-1 and PI 3-kinase activity. The current study has focused on the first steps of the insulin signaling pathway and shows that GH elevation makes the liver irresponsive to exogenous insulin at the studied transduction events. Activation of the analyzed steps by chronic hyperinsulinemia may play an important role in the observed alteration. Chronic basal hyperinsulinemia has been suggested as a major contributing factor in the development of insulin resistance in some studies (Rizza et al. 1985 , Del Prato et al. 1994 . The liver of bGHtransgenic mice may be responding to the high endogenous insulin levels, resulting in higher than normal Figure 4 PI 3-kinase activity (phosphotyrosine immunoprecipitable) and p85 protein abundance in livers from normal control and GH-transgenic mice. Animals were anesthetized, and normal saline (-) or insulin (10 IU/kg) (+) was injected into the portal vein. Liver proteins were isolated as described in Materials and Methods. After centrifugation, aliquots from the supernatants containing equal amounts of protein were incubated with PY and protein A-Sepharose. PI 3-kinase was assayed in the immunoprecipitates in the presence of phosphatidylinositol and [ -32 P]ATP. The lipid products were separated by TLC. Two animals per group were studied in each experiment (A). In (B) the spots that co-migrated with a PI 4-phosphate standard (PIP) were quantitated by densitometry. Values are expressed as a percentage of the mean densitometric units of the insulin-stimulated control mice. Data are means S.E.M. of three separate experiments (n=6). *P<0·05 versus saline-treated control mice. (C) Aliquots from total liver extracts containing equal amounts of protein (200 µg) were separated by SDS-PAGE and immunoblotted with p85 as described in Materials and Methods. (D) Quantitation of p85 content was performed by scanning densitometry. The abundance of p85 in livers of 2 control and 2 transgenic mice is shown. Data are means S.E.M. of three separate experiments (n=6).
activation of the IR tyrosine kinase in vivo. This, in turn, would lead to an increase in the basal tyrosine phosphorylation levels of the IRS-1, elevated basal association of IRS-1 with the p85 subunit of PI 3-kinase and supranormal basal activity of PI 3-kinase. Under these altered basal conditions, additional insulin administered exogenously would cause little, if any, effect. However, the possibility of a direct effect of the elevation of GH on the studied components of the insulin signaling system cannot be excluded, as GH appears capable of directly affecting the insulin signaling pathway in vivo, particularly the phosphorylation of IRS-1 and the subsequent activation of the PI 3-kinase (Yamauchi et al. 1998) . Even though the GH-induced tyrosine phosphorylation of IRS-1 and PI 3-kinase was demonstrated to be much lower than that induced by insulin under the same conditions (Yamauchi et al. 1998) , the alterations detected in the insulin signaling system in liver of GH-transgenic mice could involve, at least partially, the direct phosphorylation of IRS-1 mediated by the growth hormone receptor-JAK2 complex. Therefore, the current results could be explained by a combination of the effects of chronic elevation of both insulin and GH levels.
In summary, in the current study we have shown that in the liver of GH-transgenic mice there is a major increase in the tyrosine phosphorylation of the IR in the basal state and that the tyrosine phosphorylation of IRS-1, its association with PI 3-kinase as well as the phosphotyrosine associated activity of this lipid kinase are maximal in the basal state and thus unable to increase any further in response to insulin stimulation. Consequently, these signaling steps are insensitive to insulin.
